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reported as the major phytoconstituents of this species. Different pharmacological experiments in a
number of in vitro and in vivo models have convincingly demonstrated the ability of F. vulgare to
exhibit antifungal, antibacterial, antioxidant, antithrombotic and hepatoprotective activities, lend-
ing support to the rationale behind several of its therapeutic uses. Phenolic compounds isolated
from F. vulgare are considered to be responsible for its antioxidant activity while the volatile aroma
compounds make it an excellent ﬂavouring agent. The present review is an up-to-date and compre-
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Trans- anethole
O
Fenchone1. Introduction
Foeniculum vulgare Mill. is a biennial medicinal and aromatic
plant belonging to the family Apiaceae (Umbelliferaceae). It
is a hardy, perennial–umbelliferous herb with yellow ﬂowers
and feathery leaves. It grows to a height of up to 2.5 m with
hollow stems. The leaves grow up to 40 cm long; they are ﬁnely
dissected with the ultimate segments ﬁliform (thread like) of
about 0.5 mm wide. The ﬂowers are produced in terminal com-
pound umbels. The fruit is a dry seed 4–10 mm long. It is gen-
erally considered indigenous to the shores of Mediterranean
Sea but has become widely naturalised in many parts of the
world especially on dry soils near the sea coast and on the river
banks. Some authors distinguish two sub-species of fennel, pip-
eritum and vulgare: sub-species piperitum has bitter seeds, while
sub-species vulgare has sweet seeds which are used as ﬂavour-
ing agents in baked goods, meat and ﬁsh dishes, ice creams,
alcoholic beverages, etc due to their characteristic anise odour
(Diaaz-Maroto et al., 2006). Morphological differences be-
tween these two sub-species are not always clearly deﬁned.H3CO
Estragol
O
O
Para-anisaldehyde
alpha-phellandrene
Figure 1 The molecular structures of the major bioactive
essential oil components of Foeniculum vulgare.2. Culinary uses
It is a highly aromatic and ﬂavourful herb with culinary and
medicinal uses. Fennel seeds are anise like in aroma and are
used as ﬂavourings in baked goods, meat and ﬁsh dishes, ice
cream, alcoholic beverages and herb mixtures (Diaaz-Maroto
et al., 2005). The bulb, foliage and seeds of the fennel plant
are widely used in many of the culinary traditions of the world.
Dried fennel seed is an aromatic, anise-ﬂavoured spice, brown
or green in colour when fresh, slowly turning a dull grey as the
seed ages. For cooking green seeds are the best. The bulb is acrisp, hardy root vegetable and may be saute´ed, stewed,
braised, grilled or eaten raw. Fennel features predominantly
in Mediterranean cuisine, where bulbs and fronds are used,
both raw and cooked, in side dishes, salads, pastas, vegetable
dishes. Many cultures in the Indian subcontinent and the Mid-
dle East use fennel seeds in their cooking. Fennel is one of the
most important spices in Kashmiri Pandit and Gujarati cook-
ing (Grieve, 1931).
S1576 M.A. Rather et al.3. Use in local and traditional medicine
On account of its carminative properties, fennel is chieﬂy used
medicinally with purgatives to allay their side effects and for
this purpose forms one of the ingredients of the well known
compound liquorice powder. Fennel water has properties sim-
ilar to those of anise and dill water: mixed with sodium bicar-
bonate and syrup, these waters constitute the domestic ‘gripe
water’, used to correct ﬂatulence of infants. Fennel tea, also
employed as a carminative, is made by pouring boiling water
on a teaspoonful of bruised fennel seeds. In the Indian Subcon-
tinent, fennel seeds are eaten raw, sometimes with some sweet-
ener to improve eyesight. Extracts of fennel seeds have been
shown in animal studies to have a potential use in the treat-
ment of glaucoma, as a diuretic and a potential drug for the
treatment of hypertension. It has been used as a galactagogue
improving the milk supply of a breast feeding mother. This isO
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Figure 2 Molecular structures of some phenols and phsuggested to be due to the presence of phytoestrogens present
in fennel which promote growth of breast tissue (Agarwal
et al., 2008).
The objective of this review article is to present the existing
knowledge of F. vulgare’s phytochemical composition, its culi-
nary uses, use in local medicine, and reported in vitro and
in vivo pharmacological studies on plant-derived extracts, iso-
lated phytochemicals and also to highlight the potential for
developing evidence-based F. vulgare preparations.
4. Phytochemistry
F. vulgare has been reported to contain 6.3% of moisture,
9.5% protein, 10% fat, 13.4% minerals, 18.5% ﬁbre and
42.3% carbohydrates. The minerals and vitamins present in
F. vulgare are calcium, potassium, sodium, iron, phosphorus,
thiamine, riboﬂavin, niacin and vitamin C.OO
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F. vulgare is well known for its essential oil. The characteristic
anise odour of F. vulgare which is due to its essential oil makes
it an excellent ﬂavouring agent in baked goods, meat and ﬁsh
dishes, ice-cream and alcoholic beverages. The major compo-
nents of F. vulgare seed essential oil have been reported to
be trans-anethole, fenchone, estragol (methyl chavicol), and
a-phellandrene, their molecular structures are shown in
Fig. 1. The relative concentration of these compounds varies
considerably depending on the phonological state and origin
of the fennel (Diaaz-Maroto et al., 2006). The essential oil
composition of F. vulgare exhibits considerable chemodiversity
depending upon the method of extraction and geographical
origin. The accumulation of these volatile compounds inside
the plant is variable, appearing practically in any of its parts
viz. roots, stem, shoots, ﬂowers and fruits (Diaaz-Maroto
et al., 2006; Gross et al., 2009). In one study it was reported
that the essential oil content and composition varies during
the different maturation stages of F. vulgare. The essential
oil content was reported to decline with fruit maturity. The
content of trans-anethole, the main component, varied be-
tween 81.63% and 87.85% (Telci et al., 2009). Another study
reported that the phenylpropenes estragol and trans-anethole
which are the major constituents of the oleoresin of the aerial
parts of F. vulgare varied during plant development, these two
compounds being maximal in ﬂowers and developing meri-
carps. The pharmacological effects of the F. vulgare fruits
are generally attributed to their essential oil. Numerous studies
have shown that the essential oil and its individual constituents
exhibit novel pharmacological activities. (+) Fenchone and P-
anisaldehyde were identiﬁed as the major acaricidal agents
against Dermatophagoides farinae and Dermatoghagoides pter-
onyssinus. Hence these compounds can be used as potential
house dust mite control agents or as lead compounds. In an-
other study, anethole has been reported to be active oestrogen-
ic agent. However, in some studies it has been shown that
polymers of anethole i.e. dianethole and photoanethole areOHO
OH O
OCH3
Acacetin
O
OH
HO
OH O
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HO
Figure 3 Molecular structures of some ﬂavonothe actual oestrogenic agents. Anethole has been also reported
to be a safe antithrombotic agent due to its antiplatelet activ-
ity, clot destabilising effect and vaso-relaxant action (Togno-
lini et al., 2007). However, estragole, a main component of
F. vulgare has become a cause of concern, as the structurally
similar methyleugenol has been recently found to be a poten-
tial carcinogen. This has led to the European Union (EU) to
allow a new legal limit for estragole of 10 mg/kg in non-alco-
holic beverages (Zeller and Rychlik, 2006).
The other classes of phytochemicals present in F. vulgare
are phenols and phenolic glycosides, the chemical structures
of some of these phytochemicals are shown in Fig. 2. The struc-
tures of some of the ﬂavonoid aslycones and miscellaneous
compounds are given in Figs. 3 and 4. F. vulgare has been re-
ported to contain phenolic acids like 3-O-Caffeoylquinic acid,
4-O-caffeoylquinic acid, 5-O-caffeoylquinic acid, 1,3-O-di-caf-
feoylquinic acid, 1,4-O-di-caffeoylquinic acid, 1,5-O-di-caf-
feoylquinic acid. The ﬂavonoids like eriodictyol-7-rutinoside,
quercetin-3-rutinoside and rosmarinic acid have also been
isolated from F. vulgare (Faudale et al., 2008; Park, 1996).
Quercetin-3-O-galactoside, kaempferol-3-O-rutinoside and
kaempferol-3-O-glucoside have also been reported to occur
in the aqueous extract of F. vulgare. Quercitin-3-O-glucuro-
nide, kampferol-3-O-glucuronide, isoquercitin and isorhamne-
tin-3-O-glucoside have also been isolated from F. vulgare
Parejo et al., 2004a). The phenolic compounds present in F.
vulgare are considered to be associated with the prevention
of diseases thought to be induced by oxidative stress such as
cardiovascular diseases, cancer and inﬂammation. These phe-
nolic compounds have received tremendous attention among
nutritionists, food scientists and consumers due to their roles
in human health. Diglucoside stilbene trimers and benzoisof-
uranone derivatives have also been isolated from F. vulgare
fruit together with cis-miyabenol C, trans-miyabenol C,
trans-resveratrol-3-O-b-D-glucopyranoside, sinapyl glucoside,
syringin-4-O-b-glucoside, oleanolic acid, 7a-hydroxycampes-
terol, (3b,5a,8a,22E) 5,8-epidioxy-ergosta-6,22-dien-3-ol, and
2,3-dihydropropylheptadec-5-onoate (Marino et al., 2007).O
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Figure 4 Molecular structures of some miscellaneous compounds isolated from Foeniculum vulgare.
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also been isolated (Soliman et al., 2002) (see Figs. 3–5).5. Pharmacology
5.1. Antibacterial activity
The essential oil extracted from the fruits of F. vulgare exhib-
ited antibacterial effect against foodborne pathogens such as
Escherichia coli, Bacillus megaterium and Staphylococcus aur-
eus (Mohsenzadeh, 2007), E. coli 0157:H7, Listeria monocytog-
enes and S. aureus (Dadalioglu and Evrendilek, 2004; Cantore
et al., 2004). Aqueous and organic extracts of F. vulgare have
been reported to show antibacterial activity against some bac-
terial strains (Kaur and Arora, 2008). The seed essential oil of
F. vulgare has also been reported to possess antibacterial activ-
ity against some human pathogenic bacteria. Ethanol and
water extracts of F. vulgare have shown activity against Cam-pylobacter jejuni and Helicobacter pylori (Mahady et al., 2005).
In another study, the F. vulgare essential oil has been shown to
exhibit potential for the control of multidrug resistant Acineto-
bacter baumannii infections. Some chemical constituents from
F. vulgare have been identiﬁed as active antimicrobial princi-
ples such as a phenyl propanoid derivative – Dillapional was
found to be the active antimicrobial principle of the F. vulgare
stem. Another molecule – Scopoletin which is a coumarin
derivative has been isolated from F. vulgare and reported to
possess marginal antimicrobial effect (Kwon et al., 2002).
5.2. Antifungal activity
The fennel essential oil has been reported to exhibit antifungal
effect. The fennel essential oil and its seed extracts have been
reported to exhibit antimycobacterial and anticandidal activity
(Abed, 2007). Various bark extracts of F. vulgare have also
been reported to possess antifungal activity against Candida
albicans (Pai et al., 2010). The essential oil of F. vulgare has
OR3
R1
R2
OCH3              H                   CH3                             Methyl 4-methoxy benzoate
OCH3               H                   H                          4-Methoxy benzaldehyde
OCH3            H                   OH                       4-Methoxy benzoic acid
OCH3         OCH3            OH                       3,4-Dimethoxy benzoic acid
OH             OCH3               OH                       4-hydroxy-3-methoxybenzoic acid
R1                      R2                       R3
OO
OCH3
O
5-methoxypsoralen (5-MOP)
COOH
HO
HO
Caffeic acid
O
R
O
R = OH, 3-butyl-5-hydroxyphthalate
R = OCH3, 3-butyl-5-methoxyphthalate
Figure 5 Molecular structures of bioactive compounds from the methanol extract of F. vulgare seeds. These compounds have been
reported to possess human liver cytochrome P 450 3A4 inhibitory activity with 5-methoxypsoralen showing the strongest inhibition.
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tion of Sclerotinia sclerotiorum and as such could be used as
bio fungicide alternative to synthetic fungicides against phyto-
pathogenic fungi (Soylu et al., 2007). The essential oil of F.
vulgare has been reported to show complete zone of inhibition
against Aspergillum niger, Aspergillum ﬂavus, Fusarium grami-
nearum and Fusarium moniliforme at 6 ll dose (Singh et al.,
2006).
5.3. Antioxidant activity
The antioxidant activity of wild, edible and medicinal fennels
from different Mediterranean countries has been determined.
Wild fennel has been found to exhibit a radical scavenging
activity higher than that of both medicinal and edible fennels
(Faudale et al., 2008). The methanolic extract of F. vulgare
fruit has also been reported to exhibit antioxidant activity by
decreasing the malondialdehyde level in F. vulgare fruit meth-
anol extract group compared to the control group. The essen-
tial oil and acetone extracts of F. vulgare have been reported to
exhibit strong antioxidant activity in comparison with butyl-ated hydroxyanisole (BHA) and butylated hydroxytoluene
(BHT) (Ruberto et al., 2000). The inhibitory action of oil
and the acetone extracts in linoleic acid system was studied
by monitoring peroxide accumulation in emulsion during incu-
bation through ferric thiocyanate method. F. vulgare fruit ex-
tract and the puriﬁed compounds namely cis-miyabenol C
11a-O-b-D-glucopyranosyl-(1ﬁ6)-b-D-glucopyranoside, cis-
miyabenol C, trans-miyabenol C, sinapyl glucoside and syring-
ing 4-O-b-glucoside have been reported to exhibit antioxidant
activity. The n-BuOH extract of the F. vulgare fruit showed a
moderate activity in the lipid peroxidation assay but strong
activity at the higher tested concentration. Pure compounds
isolated from F. vulgare showed higher antioxidant activity
than the crude extracts (Marino et al., 2007).
The isolated phenolic compounds from the residue of ﬂow-
ering aerial parts of the bitter fennel resulting from its distilla-
tion for essential oils have been reported to possess strong
antiradical scavenging activity which may contribute to the
interpretation of the pharmacological effect of F. vulgare.
The isolated compounds were characterised as 3-caffeoylquinic
acid, 4-caffeoylquinic acid, 1,5-O-dicaffeoylquinic acid, ros-
S1580 M.A. Rather et al.marinic acid, eriodictyol-7-rutinoside, quercetin-3-O-galacto-
side, kaempferol-3-O-rutinoside and kaempferol-3-O-gluco-
side. (Parejo et al., 2004b). In another study water and
ethanol extracts of F. vulgare seeds have been reported to dis-
play antioxidant activity. 100 lg of water and ethanol extracts
exhibited 99.1% and 77.5% inhibition of peroxidation in lino-
leic acid system respectively and greater than the same dose of
a-tocopherol (36.1%). Both extracts were reported to have
effective reducing power, free radical scavenging, superoxide
anion radical scavenging, hydrogen peroxide scavenging and
metal chelating activities. Essential oils of the fruits of three
organically grown cultivars of Egyptian fennel (F. vulgare
var. azoricum, F. vulgare var. dulce and F. vulgare var. vulgare)
were reported to possess antioxidant activity. Essential oils
from the azoricum and dulce cultivars were more effective anti-
oxidants than those from the vulgare cultivar (Shahat et al.,
2011).
5.4. Antithrombotic activity
The essential oil of F. vulgare and its main component, ane-
thole has been shown to have a safe antithrombotic activity
that originates due to their broad-spectrum antiplatelet activ-
ity, clot destabilizing effect and vasorelaxant action. Anethole,
the main component of fennel oil tested in guinea pig plasma
was as potent as the fennel oil in inhibiting arachidonic acid,
collagen-ADP and U46619 induced aggregation. Anethole also
prevented thrombin induced clot reaction at concentrations
similar to fennel oil. The fennel oil and anethole were tested
in rat aorta with or without endothelium and displayed com-
parable NO-independent vasorelaxant activity at antiplatelet
concentrations which have been proved to be free from cyto-
toxic effects in vitro. Furthermore, both F. vulgare essential
oil and anethole (100 mg/kg oral administration) provided sig-
niﬁcant protection towards ethanol induced gastric lesions in
rats (Tognolini et al., 2007).
5.5. Anti-inﬂammatory activity
Oral administration (200 mg/kg) of F. vulgare fruit methanolic
extract has been reported to show inhibitory effects against
acute and subacute inﬂammatory diseases and type IV allergic
reactions (Choi and Hwang, 2004).
5.6. Oestrogenic activity
F. vulgare has been used as an oestrogenic agent for centuries.
It has been reported to increase milk secretion, promote men-
struation, facilitate birth, alleviate the symptoms of the male
climacteric and increase libido. The main constituent of fennel
essential oil, anethole has been considered to be the active oes-
trogenic agent. Some other studies have suggested that the ac-
tual pharmacologically active agents are polymers of anethole,
such as dianethole and photoanethole (Albert-puleo, 1980).
5.7. Hepatoprotective activity
The fennel essential oil has been reported to possess hepato-
protective activity. In a study, the hepatotoxicity produced
by acute CCl4 administration was found to be inhibited by fen-nel essential oil with evidence of decreased levels of serum
aspartate aminotransferase (AST), alanine aminotransferase
(ALT), alkaline phosphatase (ALP) and bilirubin (Ozbek
et al., 2003).
5.8. Antidiabetic activity
The essential oil of F. vulgare has been reported to show hypo-
glycaemic activity in Streptozotocin induced diabetic rats.
Ingestion of essential oil of F. vulgare to diabetic rats corrected
the hyperglycaemia from (162.5 + 3.19 mg/dl) to
(81.97 + 1.97 mg/dl) and the activity of serum glutathione
peroxidise from (59.72 + 2.78 u/g Hb) to (99.60 + 6.38 u/g
Hb). This makes the possibility of its inclusion in antidiabetic
drug industry (El-Soud et al., 2011).
5.9. Miscellaneous
5.9.1. In vitro cytoprotection and antitumour activity
The methanolic extract of F. vulgare has been reported to ex-
hibit in vitro cytoprotective activity against normal human
blood lymphocytes by micronucleus assay and anti-tumour
activity against B16F10 melanoma cell line by trypan blue
exclusion assay for cell viability. Lymphocyte culture treated
with 70% methanolic extract of F. vulgare showed very less
percentage of micronucleus i.e. 0.006% as compared to stan-
dard drug doxorubicin which showed 0.018% micronucleus.
On the other hand 70% methanolic extract of F. vulgare
showed good anti-tumour activity at the concentration of
200 lg/ml. This suggests that F. vulgare could be considered
as a natural resource of antitumour agents as well as cytopro-
tective to normal cells (Pradhan et al., 2008).
5.9.2. Acaricidal activity
F. vulgare fruit oil has been reported to possess acaricidal
activity against D. farinae and D. pteronyssinus using direct
contact application and compared with that of the commercial
repellent benzyl benzoate. The biologically active constituents
of the F. vulgare fruit oil have been identiﬁed as P-anisalde-
hyde, (+)-fenchone, ()-fenchone, thymol and estragol (Lee,
2004).
The methanol extract of F. vulgare fruit has been reported
to exhibit mosquito repellent activity against Aedes aegypti fe-
males using skin and patch tests. The biologically active con-
stituents of the Foeniculum fruits were characterised as (+)-
fenchone and (z)-9-octadecanoic acid (Kim et al., 2002).
5.9.3. Antihirustism activity
The ethanolic extract of F. vulgare has been reported to display
antihirustism activity. In a double blind study patients were
treated with creams containing 1%, 2% of fennel extract and
placebo. The cream containing 2% fennel is better than the
cream containing 1% fennel (Javidnia et al., 2003).
5.9.4. Effect on uterine contraction
The effects of fennel essential oil on the uterine contraction in
rats have been reported. Administration of different doses of
fennel essential oil reduced the intensity of oxytocin and
PGE2 induced contractions signiﬁcantly (25 and 50 lg/ml for
oxytocin and10 and 20 lg/ml for PGE2 respectively). Fennel
Figure 6 Metabolism of estragole (suggested biotransformation of estragole in experimental animals leading to the formation of
mutagenic metabolites (adapted from Punt et al., 2008).
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by PGE2 but not with oxytocin. The estimated LD50 obtained
in female rats by moving average method was 1326 mg/kg.
Furthermore, no obvious damage was observed in the vital or-
gans of the dead animals (Ostad et al., 2001).
5.9.5. Human liver cytochrome P450 3A4 inhibitory activity
Thirteen compounds isolated from the methanolic extract of
fennel have been found to possess human liver cytochrome
P450 3A4 inhibitory activity. Among these compounds
(Fig. 5) 5-methoxypsoralen (5-MoP) showed the strongest
inhibition with an IC50 value of 18.3 lM and with a mixed type
of inhibition. (Subehan et al., 2007).
6. Safety
The safety of medicinal and spice plants and of their prepara-
tions deserves increased scientiﬁc attention. One of the main
conditions for use of herbal preparations in medicinal condi-
tions is the absence of such risks as mutagenicity, carcinogenic-
ity, and teratogenicity. In general, such products need to have
minimal toxicity and side effects. Generally, the vast majority
of herbal remedies are recognised as safe, and individual
hypersensitivity is usually considered as the most common
but controllable risk. However, for those individual com-
pounds exhibiting toxic effects in laboratory animals, the ques-
tion of possible negative effects in humans remains open. In
the case of F. vulgare some compounds have come under scru-
tiny, most importantly, estragole.Estragole (Methylchavicol) is one of themain components of
the essential oil of F. vulgare. It has been reported that estragole
is associated with the development of malignant tumours in ro-
dents. This was the basis for the recommendations of the Scien-
tiﬁc Committee on Food (SCF) of the European Union to
restrict the use of this substance (Opinion of the Scientiﬁc Com-
mittee on Estragole, 2001) but the potential of estragole to in-
duce carcinogenesis in humans remains unclear. The ability of
estragole to cause genotoxicity and, thus, to be carcinogenic
was ﬁrst described by Drinkwater (Drinkwater et al., 1976)
and then followed by numerous in vivo and in vitro studies
(Swanson et al., 1979, 1981;Miller et al., 1983;Miller andMiller,
1983; Paini et al., 2010). It was found that estragole possesses tis-
sue-, species-, and sex-speciﬁc carcinogenic effects. According to
recent evidence, estragole does not have a direct carcinogenic ac-
tion. The essential factor for estragole’s carcinogenicity is its
metabolic activation, leading to the formation of unstable mol-
ecules and active radicals that form adducts with nucleic acids
and thus damage DNA (Phillips, 1994). Estragole metabolism
(Fig. 6) is dose-dependent and elevated doses of estragole in-
crease its biotransformation, leading to the formation of muta-
genic metabolites (Punt et al., 2008). The biotransformation of
the same substance can differ in animals and in humans, which
raises the question of whether the mutagenic metabolites of
estragole are formed in humans.
7. Conclusion
F. vulgare is a medicinal and aromatic plant with a diverse
pharmacological spectrum and having considerable impor-
S1582 M.A. Rather et al.tance in particular to food industry. Its aroma active com-
pounds such as anethole (and its polymers like dianethole
and photoanethole) estragole, (+)-Fenchone and P-anisalde-
hyde have been recognised as the biologically active mole-
cules possessing oestrogenic, acaricidal and antithrombotic
activities. The phenolic molecules present in fennel have been
shown to possess potent antioxidant activity in a number of
experiments. These bioactive molecules in fennel can be
developed as novel pharmacological lead molecules provided
their bioavailability, pharmacokinetics, physiological path-
ways, and importance to human health are known with suf-
ﬁcient detail.
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